Previous 10 |
Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpar...
The market is trading at some of the most overvalued levels in 20 years. Over the next five years, analysts expect 5% CAGR returns from the S&P 500. That's about 1/3 of what investors have enjoyed for the last decade. But it's a market of stocks, not a stock market, and incredible...
Healthcare sector and Real Estate Select Sector SPDR ETF (XLRE) gain of 1.92% and 1.88% respectively during the week outpaced S&P 500 gain of +0.40%.Looking at larger stocks (over $2B market capitalization), far and away the sector's top gainer was "meme stock" favorite ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...